Form 8-K
8-K — BRUKER CORP
Accession: 0001193125-26-449782
Filed: 2026-11-05
Period: 2026-11-05
CIK: 0001109354
SIC: 3826 (LABORATORY ANALYTICAL INSTRUMENTS)
Item: Other Events
Item: Financial Statements and Exhibits
Documents
8-K — brkr-20261105.htm (Primary)
EX-99.1 (brkr-ex99_1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: brkr-20261105.htm · Sequence: 1
8-K
0001109354false00011093542026-11-052026-11-050001109354us-gaap:CommonStockMember2026-11-052026-11-050001109354brkr:SixPointThreeSevenFivePercentageMandatoryConvertiblePreferredStockSeriesAMember2026-11-052026-11-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 5, 2026
BRUKER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
000-30833
04-3110160
(State or other jurisdiction of
(Commission
(I.R.S. Employer
incorporation)
File number)
Identification No.)
40 Manning Road
Billerica, MA 01821
(Address of principal executive offices) (Zip Code)
(978) 663-3660
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common Stock, $0.01 par value per share
BRKR
The Nasdaq Global Select Market
6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share
BRKRP
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
As previously announced, effective July 1, 2026 (the “Effective Date”), Bruker Corporation (the “Company”) completed a reorganization of its reportable segments to streamline its organizational structure and further facilitate decision making, accountability, customer focus, and innovation. Prior to the Effective Date, the Company had the following four reportable segments: (i) Bruker Scientific Instruments (“BSI”) BioSpin, (ii) BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), (iii) BSI NANO, and (iv) Bruker Energy & Supercon Technologies (“BEST”).
As a result of this reorganization, as of the Effective Date, the Company’s reportable segments consist of the following four reportable segments:
•
BSI BIOS, consisting of:
o
The BioSpin division, which combines the former Magnetic Resonance Spectroscopy, Preclinical Imaging, Biopharma and Applied Services, and Services and Lifecycle Support divisions, all of which were previously part of the former BSI BioSpin segment;
o
The SciY (formerly Integrated Data Solutions) division, previously part of the former BSI BioSpin segment;
o
The Chemspeed Technologies (“CST”) (formerly Automation) division, previously part of the former BSI BioSpin segment;
o
The Daltonics division (formerly Bruker Life Sciences Mass Spectrometry and Bruker Applied Mass Spectrometry), previously part of the former BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection) segment;
o
The Optics division, previously part of the former BSI CALID segment; and
o
The Mimetas division, a new division formed during the third quarter of 2026 following the acquisition of a majority interest in Mimetas B.V.
•
BSI Microbiology and Infection Diagnostics (“BMID”), consisting of the Microbiology, Molecular Diagnostics, and Biomedical Systems divisions, which were previously part of the former BSI CALID segment.
•
BSI NANO, for which no changes were made to the reportable segment structure in connection with the reorganization.
•
BEST, for which no changes were made to the reportable segment structure in connection with the reorganization.
For information purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has provided recast reportable segment information that conforms to the new reporting structure. This reportable operating segment realignment did not impact the Company’s historical consolidated results of operations, financial position or cash flows.
Attached as Exhibit 99.1 and incorporated by reference in this Item 8.01 are schedules containing recast reportable segment information for the years ended December 31, 2025 and 2024, the three months ended March 31, 2025 and 2026, the three and six months ended June 30, 2025 and 2026, and the three and nine months ended September 30, 2025. The recast information has been derived from, and should be read in conjunction with, the Company's previously filed Annual Reports on Form 10-K for the years ended December 31, 2025 and 2024, and Quarterly Reports on Form 10-Q for the periods ended March 31, 2025 and 2026, June 30, 2025 and 2026, and September 30, 2025, in which the corresponding financial information was originally reported.
As noted above, the segment changes and supplemental disclosures discussed above have no impact on the Company’s historical consolidated results of operations, financial position or cash flows. The recast financial information contained in Exhibit 99.1 does not represent a restatement of the Company’s previously issued financial statements.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits.
Number
Description
99.1
Recast segment information of Bruker Corporation
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BRUKER CORPORATION
(Registrant)
Date: November 5, 2026
By:
/s/ THOMAS M. BURES
Thomas M. Bures
Chief Accounting Officer
EX-99.1
EX-99.1
Filename: brkr-ex99_1.htm · Sequence: 2
EX-99.1
Exhibit 99.1
As Reported
As Recast
Bruker Scientific Instruments ("BSI") BioSpin
BSI Chemicals, Applied Markets, Life Sciences, In Vitro Diagnostics, Detection ("BSI CALID")
BSI NANO
Bruker Energy & Supercon Technologies ("BEST")
Corporate
Total
BSI Biosystems ("BIOS")
BSI Microbiology and Infection Diagnostics ("BMID")
BSI NANO
BEST
Corporate
Total
Three months ended March 31, 2026
Revenue from external customers
$
197.5
$
316.3
$
246.0
$
63.6
—
$
823.4
$
381.5
$
132.3
$
246.0
$
63.6
—
$
823.4
Intersegment revenue
—
—
—
3.2
—
3.2
—
—
—
$
3.2
—
3.2
Total segment revenue
$
197.5
$
316.3
$
246.0
$
66.8
—
$
826.6
$
381.5
$
132.3
$
246.0
$
66.8
—
$
826.6
Gross profit
$
88.9
$
167.7
$
109.1
$
14.1
—
$
379.8
$
178.7
$
77.9
$
109.1
$
14.1
—
$
379.8
Gross profit margin
45.0
%
53.0
%
44.3
%
21.1
%
—
46.1
%
46.8
%
58.9
%
44.3
%
21.1
%
—
46.1
%
Operating income
$
16.0
$
40.7
$
(21.8
)
$
7.5
$
(32.2
)
$
10.2
$
27.4
$
29.3
$
(21.8
)
$
7.5
$
(32.2
)
$
10.2
Operating margin
8.1
%
12.9
%
(8.9
)%
11.2
%
—
1.2
%
7.2
%
22.1
%
(8.9
)%
11.2
%
—
1.2
%
As Reported
As Recast
BSI BioSpin
BSI CALID
BSI NANO
BEST
Corporate
Total
BSI BIOS
BSI BMID
BSI NANO
BEST
Corporate
Total
Three months ended June 30, 2026
Revenue from external customers
$
195.7
$
310.3
$
261.3
$
71.2
—
$
838.5
$
376.1
$
129.9
$
261.3
$
71.2
—
$
838.5
Intersegment revenue
—
—
—
3.0
—
3.0
—
—
—
3.0
—
3.0
Total segment revenue
$
195.7
$
310.3
$
261.3
$
74.2
—
$
841.5
$
376.1
$
129.9
$
261.3
$
74.2
—
$
841.5
Gross profit
$
98.8
$
172.6
$
131.4
$
13.2
—
$
416.0
$
194.8
$
76.6
$
131.4
$
13.2
—
$
416.0
Gross profit margin
50.5
%
55.6
%
50.3
%
17.8
%
—
49.6
%
51.8
%
59.0
%
50.3
%
17.8
%
—
49.6
%
Operating income
$
(64.6
)
$
48.3
$
(20.9
)
$
7.5
$
(35.6
)
$
(65.3
)
$
(45.8
)
$
29.5
$
(20.9
)
$
7.5
$
(35.6
)
$
(65.3
)
Operating margin
(33.0
)%
15.6
%
(8.0
)%
10.1
%
—
(7.8
)%
(12.2
)%
22.7
%
(8.0
)%
10.1
%
—
(7.8
)%
Six months ended June 30, 2026
Revenue from external customers
$
393.2
$
626.6
$
507.3
$
134.8
—
$
1,661.9
$
757.6
$
262.2
$
507.3
$
134.8
—
$
1,661.9
Intersegment revenue
—
—
—
6.2
—
6.2
—
—
—
6.2
—
6.2
Total segment revenue
$
393.2
$
626.6
$
507.3
$
141.0
—
$
1,668.1
$
757.6
$
262.2
$
507.3
$
141.0
—
$
1,668.1
Gross profit
$
187.6
$
340.3
$
240.5
$
27.4
—
$
795.8
$
373.4
$
154.5
$
240.5
$
27.4
—
$
795.8
Gross profit margin
47.7
%
54.3
%
47.4
%
19.4
%
—
47.9
%
49.3
%
58.9
%
47.4
%
19.4
%
—
47.9
%
Operating income
$
(48.6
)
$
89.0
$
(42.7
)
$
15.0
$
(67.8
)
$
(55.1
)
$
(18.4
)
$
58.8
$
(42.7
)
$
15.0
$
(67.8
)
$
(55.1
)
Operating margin
(12.4
)%
14.2
%
(8.4
)%
10.6
%
—
(3.3
)%
(2.4
)%
22.4
%
(8.4
)%
10.6
%
—
(3.3
)%
As Reported
As Recast
BSI BioSpin
BSI CALID
BSI NANO
BEST
Corporate
Total
BSI BIOS
BSI BMID
BSI NANO
BEST
Corporate
Total
Three months ended March 31, 2025
Revenue from external customers
$
207.8
$
280.1
$
256.6
$
56.9
—
$
801.4
$
368.9
$
119.0
$
256.6
$
56.9
—
$
801.4
Intersegment revenue
—
—
—
2.4
—
2.4
—
—
—
2.4
—
2.4
Total segment revenue
$
207.8
$
280.1
$
256.6
$
59.3
—
$
803.8
$
368.9
$
119.0
$
256.6
$
59.3
—
$
803.8
Gross profit
$
93.7
$
153.3
$
131.4
$
12.8
—
$
391.2
$
178.9
$
68.1
$
131.4
$
12.8
—
$
391.2
Gross profit margin
45.1
%
54.7
%
51.2
%
21.6
%
—
48.8
%
48.5
%
57.2
%
51.2
%
21.6
%
—
48.8
%
Operating income
$
23.7
$
40.2
$
(7.0
)
$
6.9
$
(32.0
)
$
31.8
$
40.5
$
23.4
$
(7.0
)
$
6.9
$
(32.0
)
$
31.8
Operating margin
11.4
%
14.4
%
(2.7
)%
11.6
%
—
4.0
%
11.0
%
19.7
%
(2.7
)%
11.6
%
—
4.0
%
Three months ended June 30, 2025
Revenue from external customers
$
195.3
$
285.8
$
252.1
$
64.2
—
$
797.4
$
357.0
$
124.1
$
252.1
$
64.2
—
$
797.4
Intersegment revenue
—
—
—
2.1
—
2.1
—
—
—
2.1
—
2.1
Total segment revenue
$
195.3
$
285.8
$
252.1
$
66.3
—
$
799.5
$
357.0
$
124.1
$
252.1
$
66.3
—
$
799.5
Gross profit
$
83.4
$
145.3
$
115.9
$
13.3
—
$
357.9
$
157.6
$
71.1
$
115.9
$
13.3
—
$
357.9
Gross profit margin
42.7
%
50.8
%
46.0
%
20.1
%
—
44.9
%
44.1
%
57.3
%
46.0
%
20.1
%
—
44.9
%
Operating income
$
18.1
$
26.2
$
(13.4
)
$
7.2
$
(26.2
)
$
11.9
$
18.3
$
26.0
$
(13.4
)
$
7.2
$
(26.2
)
$
11.9
Operating margin
9.3
%
9.2
%
(5.3
)%
10.9
%
—
1.5
%
5.1
%
21.0
%
(5.3
)%
10.9
%
—
1.5
%
Six months ended June 30, 2025
Revenue from external customers
$
403.1
$
565.9
$
508.7
$
121.1
—
$
1,598.8
$
725.9
$
243.1
$
508.7
$
121.1
—
$
1,598.8
Intersegment revenue
—
—
—
4.5
—
4.5
—
—
—
4.5
—
4.5
Total segment revenue
$
403.1
$
565.9
$
508.7
$
125.6
—
$
1,603.3
$
725.9
$
243.1
$
508.7
$
125.6
—
$
1,603.3
Gross profit
$
177.1
$
298.7
$
247.3
$
26.0
—
$
749.1
$
336.6
$
139.2
$
247.3
$
26.0
—
$
749.1
Gross profit margin
43.9
%
52.8
%
48.6
%
20.7
%
—
46.9
%
46.4
%
57.3
%
48.6
%
20.7
%
—
46.9
%
Operating income
$
41.7
$
66.4
$
(20.4
)
$
14.1
$
(58.1
)
$
43.7
$
58.7
$
49.4
$
(20.4
)
$
14.1
$
(58.1
)
$
43.7
Operating margin
10.3
%
11.7
%
(4.0
)%
11.2
%
—
2.7
%
8.1
%
20.3
%
(4.0
)%
11.2
%
—
2.7
%
As Reported
As Recast
BSI BioSpin
BSI CALID
BSI NANO
BEST
Corporate
Total
BSI BIOS
BSI BMID
BSI NANO
BEST
Corporate
Total
Three months ended September 30, 2025
Revenue from external customers
$
208.7
$
312.7
$
266.5
$
72.6
—
$
860.5
$
391.2
$
130.2
$
266.5
$
72.6
—
$
860.5
Intersegment revenue
—
—
—
1.2
—
1.2
—
—
—
1.2
—
1.2
Total segment revenue
$
208.7
$
312.7
$
266.5
$
73.8
—
$
861.7
$
391.2
$
130.2
$
266.5
$
73.8
—
$
861.7
Gross profit
$
90.4
$
159.0
$
118.4
$
11.6
—
$
379.4
$
172.9
$
76.5
$
118.4
$
11.6
—
$
379.4
Gross profit margin
43.3
%
50.8
%
44.4
%
15.7
%
—
44.1
%
44.2
%
58.8
%
44.4
%
15.7
%
—
44.1
%
Operating income
$
8.5
$
47.4
$
(72.2
)
$
4.6
$
(40.1
)
$
(51.8
)
$
24.6
$
31.3
$
(72.2
)
$
4.6
$
(40.1
)
$
(51.8
)
Operating margin
4.1
%
15.2
%
(27.1
)%
6.2
%
—
(6.0
)%
6.3
%
24.0
%
(27.1
)%
6.2
%
—
(6.0
)%
Nine months ended September 30, 2025
Revenue from external customers
$
611.8
$
878.6
$
775.2
$
193.7
—
$
2,459.3
$
1,117.1
$
373.3
$
775.2
$
193.7
—
$
2,459.3
Intersegment revenue
—
—
—
5.7
—
5.7
—
—
—
5.7
—
5.7
Total segment revenue
$
611.8
$
878.6
$
775.2
$
199.4
—
$
2,465.0
$
1,117.1
$
373.3
$
775.2
$
199.4
—
$
2,465.0
Gross profit
$
267.5
$
457.6
$
365.8
$
37.6
—
$
1,128.5
$
509.4
$
215.7
$
365.8
$
37.6
—
$
1,128.5
Gross profit margin
43.7
%
52.1
%
47.2
%
18.9
%
—
45.9
%
45.6
%
57.8
%
47.2
%
18.9
%
—
45.9
%
Operating income
$
50.2
$
113.8
$
(92.6
)
$
18.7
$
(98.2
)
$
(8.1
)
$
83.3
$
80.7
$
(92.6
)
$
18.7
$
(98.2
)
$
(8.1
)
Operating margin
8.2
%
13.0
%
(11.9
)%
9.4
%
—
(0.3
)%
7.5
%
21.6
%
(11.9
)%
9.4
%
—
(0.3
)%
As Reported
As Recast
BSI BioSpin
BSI CALID
BSI NANO
BEST
Corporate
Total
BSI BIOS
BSI BMID
BSI NANO
BEST
Corporate
Total
Fiscal year ended December 31, 2025
Revenue from external customers
$
878.8
$
1,210.2
$
1,084.3
$
263.2
—
$
3,436.5
$
1,580.1
$
508.9
$
1,084.3
$
263.2
—
$
3,436.5
Intersegment revenue
—
—
—
7.7
—
7.7
—
—
—
7.7
—
7.7
Total segment revenue
$
878.8
$
1,210.2
$
1,084.3
$
270.9
—
$
3,444.2
$
1,580.1
$
508.9
$
1,084.3
$
270.9
—
$
3,444.2
Gross profit
$
389.1
$
625.6
$
516.3
$
46.7
—
$
1,577.7
$
729.1
$
285.6
$
516.3
$
46.7
—
$
1,577.7
Gross profit margin
44.3
%
51.7
%
47.6
%
17.2
%
—
45.9
%
46.1
%
56.1
%
47.6
%
17.2
%
—
45.9
%
Operating income
$
104.3
$
153.3
$
(71.8
)
$
19.4
$
(137.0
)
$
68.2
$
168.8
$
88.8
$
(71.8
)
$
19.4
$
(137.0
)
$
68.2
Operating margin
11.9
%
12.7
%
(6.6
%)
7.2
%
—
2.0
%
10.7
%
17.4
%
(6.6
%)
7.2
%
—
2.0
%
Fiscal year ended December 31, 2024
Revenue from external customers
$
905.7
$
1,093.5
$
1,098.3
$
268.9
—
$
3,366.4
$
1,577.5
$
421.7
$
1,098.3
$
268.9
—
$
3,366.4
Intersegment revenue
—
—
—
14.1
—
14.1
—
—
—
14.1
—
14.1
Total segment revenue
$
905.7
$
1,093.5
$
1,098.3
$
283.0
—
$
3,380.5
$
1,577.5
$
421.7
$
1,098.3
$
283.0
—
$
3,380.5
Gross profit
$
453.9
$
593.9
$
540.4
$
61.3
—
$
1,649.5
$
803.2
$
244.6
$
540.4
$
61.3
—
$
1,649.5
Gross profit margin
50.1
%
54.3
%
49.2
%
21.7
%
—
49.0
%
50.9
%
58.0
%
49.2
%
21.7
%
—
49.0
%
Operating income
$
157.8
$
180.0
$
2.3
$
34.9
$
(121.9
)
$
253.1
$
235.9
$
101.9
$
2.3
$
34.9
$
(121.9
)
$
253.1
Operating margin
17.4
%
16.5
%
0.2
%
12.3
%
—
7.5
%
15.0
%
24.2
%
0.2
%
12.3
%
—
7.5
%
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 5
v3.26.3
Document and Entity Information
Nov. 05, 2026
Entity Listings [Line Items]
Entity Registrant Name
BRUKER CORPORATION
Amendment Flag
false
Entity Central Index Key
0001109354
Document Type
8-K
Document Period End Date
Nov. 05, 2026
Entity Incorporation State Country Code
DE
Entity File Number
000-30833
Entity Tax Identification Number
04-3110160
Entity Address, Address Line One
40 Manning Road
Entity Address, City or Town
Billerica
Entity Address, State or Province
MA
Entity Address, Postal Zip Code
01821
City Area Code
978
Local Phone Number
663-3660
Written Communications
false
Soliciting Material
false
Pre Commencement Tender Offer
false
Pre Commencement Issuer Tender Offer
false
Entity Emerging Growth Company
false
Common Stock
Entity Listings [Line Items]
Security 12b Title
Common Stock, $0.01 par value per share
Trading Symbol
BRKR
Security Exchange Name
NASDAQ
6.375% Mandatory Convertible Preferred Stock, Series A
Entity Listings [Line Items]
Security 12b Title
6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share
Trading Symbol
BRKRP
Security Exchange Name
NASDAQ
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details
Name:
dei_EntityListingsLineItems
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=brkr_SixPointThreeSevenFivePercentageMandatoryConvertiblePreferredStockSeriesAMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: